Abstract

Hepatocellular carcinoma is a primary liver cancer that is responsible for a significant number of cancer-related deaths worldwide. The development and progression of hepatocellular carcinoma is a complex process that involves various signalling pathways and molecular mechanisms. One such pathway is the protein kinase C delta pathway, which has been shown to play a critical role in the development and progression of hepatocellular carcinoma. Diagnosis of hepatocellular carcinoma employs different techniques including use of imaging tools and biomarkers such as alpha-fetoprotein, des-gamma-carboxyprothrombin, Glypican-3, and protein kinase C delta. protein kinase C delta is a member of the protein kinase C family of serine/threonine kinases that regulates various cellular processes, including cell proliferation and differentiation. Inhibition of protein kinase C delta has been proposed as a potential therapeutic strategy for hepatocellular carcinoma. Several protein kinase C delta inhibitors have been developed and tested in preclinical studies, and some have shown promising results in inhibiting hepatocellular carcinoma cell proliferation and inducing apoptosis. Rosehip of various Rosa species are rich in biologically active compound which possess therapeutic properties such as anti-inflammatory, anti-cancerous and hepato-protectant. This study employs various bioinformatic tools to assess molecular, biological, and pharmacological activity of phytochemicals present in rosehip against protein kinase C delta. In order to choose hit compounds, a number of factors are taken into account, including biological activity, binding affinity (docking score), pharmacokinetics, physiochemical characteristics, physicochemical properties, ADME/t properties, and biological activity. Six compounds (quercetin, luteolin, p-coumaric acid, gallic acid, ferulic acid, and caffeine) out of 14 docked compounds matched the requirements. These six phytochemicals might be studied in vitro and in vivo to determine their effectiveness and efficiency.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.